Emma Alecock
Impact in
- Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 0.5%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Autoimmune and Inflammatory Disorders Research 4
-
- Rheumatoid Arthritis Research and Therapies 4
- Systemic Lupus Erythematosus Research 3
- Co-authors
- Thasia WoodworthCésar Ramos-RemusJ RovenskýAndré BeaulieuJosef S SmolenRieke AltenAndrea Rubbert‐RothJuan J. Gómez‐Reino
- Journals
- The Journal of Infectious Diseases (2 papers)American Journal of Transplantation (2 papers)Annals of the Rheumatic Diseases (2 papers)Liver Transplantation (1 paper)The Lancet (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Emma Alecock
9 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Rheumatology 2.4k
- Hematology 1.2k
- Genetics 510
- Immunology 965
- Oncology 570
Countries citing papers authored by Emma Alecock
This map shows the geographic impact of Emma Alecock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Alecock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Alecock more than expected).
Fields of papers citing papers by Emma Alecock
This network shows the impact of papers produced by Emma Alecock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Alecock. The network helps show where Emma Alecock may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma Alecock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study Hit paper breakdown → | 2009 | 609 |
| 2 | Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial Hit paper breakdown → | 2008 | 1109 |
| 3 | IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial Hit paper breakdown → | 2008 | 866 |
| 4 | Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs: The tocilizumab in combination with traditional disease‐modifying antirheumatic drug therapy study Hit paper breakdown → | 2008 | 655 |
| 5 | 2007 | 22 | |
| 6 | 2005 | 75 | |
| 7 | 2005 | 92 | |
| 8 | 2005 | 52 | |
| 9 | 2005 | 120 |
About Emma Alecock
Emma Alecock is a scholar working on Hematology, Rheumatology, Infectious Diseases, Hepatology and Epidemiology, having authored 9 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Systemic Lupus Erythematosus Research (3 papers), Herpesvirus Infections and Treatments (3 papers), Parvovirus B19 Infection Studies (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Rheumatology (2.4k citations), Hematology (1.2k citations), Genetics (510 citations), Immunology (965 citations) and Oncology (570 citations). Emma Alecock has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Thasia Woodworth, César Ramos-Remus, J Rovenský, André Beaulieu, Josef S Smolen, Rieke Alten, Andrea Rubbert‐Roth, Juan J. Gómez‐Reino, Alain Cantagrel and Joel M. Kremer. Their work appears in journals such as The Journal of Infectious Diseases, American Journal of Transplantation, Annals of the Rheumatic Diseases, Liver Transplantation and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.